Osteoporosis Management after the Occurrence of Medication-Related Osteonecrosis of the Jaw: A 13-Year Experience at a Tertiary Center [0.03%]
药物相关颌骨坏死后的骨质疏松症管理：一家三级中心的13年经验
Chun Ho Wong,Kimberly Hang Tsoi,Jingya Jane Pu et al.
Chun Ho Wong et al.
Background: We investigated osteoporosis management strategies and clinical outcomes following the occurrence of medicationrelated osteonecrosis of the jaw (MRONJ)....We examined subsequent osteoporosis management plans, fracture events, and bone mineral density (BMD). Results: Thirty-six individuals were included (mean age, 78.5 years; 94.4% women)....Individualised decisions in osteoporosis management after MRONJ are required to balance fracture risk reduction with minimising MRONJ recurrence.
Michaël R Laurent,Jolan Dupont,Wim Lemahieu et al.
Michaël R Laurent et al.
While osteoporosis treatment is generally similar in patients without or with CKD up to stage 3, there is still a lack of evidence to guide many areas of osteoporosis management in CKD stages 4-5.
Monitoring denosumab therapy using the calcium isotope marker (CIM) technology [0.03%]
利用钙同位素标记(CIM)技术监测地诺单抗的疗效
Eisenhauer Anton,Sönke Sönnichsen,Agustina Hastuti et al.
Eisenhauer Anton et al.
While further validation in larger, controlled cohorts is warranted, these findings highlight CIM's potential to enhance osteoporosis management through personalized treatment monitoring. Copyright © 2025.
Ejiao as a preventive agent for osteoporosis - a scoping review of current evidence [0.03%]
阿胶作为预防骨质疏松药物的效果：现有证据的综述研究
Yuanzhong Wang,Guiju Chen,Xia Ji et al.
Yuanzhong Wang et al.
These findings suggest that while Ejiao alone may promote osteoblast activity, its role in osteoporosis management may be more effective when combined with essential minerals.
Jordi Bover,Carlos Gómez-Alonso,Enrique Casado et al.
Jordi Bover et al.
Yong Wang,Wei Zhou
Yong Wang
Immediate risk factors for fracture recurrence after initial fractures, based on fracture liaison service dataset, and comparison with fall risk factors reported in the literature [0.03%]
基于骨折联络服务数据库的初次骨折后骨折复发的即时危险因素及与文献报道的跌倒危险因素的比较
Marie Doussiere,Yannis Hamidou,Vanessa Moukarzel et al.
Marie Doussiere et al.
Identifying those at risk is critical for targeted osteoporosis management within fall prevention strategies.
Impact of social determinants on osteoporosis treatment and secondary fracture risk after primary fragility fractures [0.03%]
社会决定因素对骨折后骨质疏松症治疗和二次骨折风险的影响
Hannah L Kralles,Amy Y Zhao,Alex Gu et al.
Hannah L Kralles et al.
This study examined the impact of social determinants of health (SDOH) on osteoporosis management and secondary fractures after primary fragility fractures....Conclusion: Adverse SDOH were associated with increased rates of secondary fractures among patients with primary fragility fractures, despite similar osteoporosis management rates between groups. Overall, osteoporosis treatment rates remain low.
Implementing a Clinical Risk Assessment Tool to Improve Bone Health in Postmenopausal Women [0.03%]
实施临床风险评估工具以改善绝经后妇女的骨骼健康
Bailey D Mosley,Terrie Platt,Tracy Brown
Bailey D Mosley
Interventions/measurements: A standardized process was designed to promote appropriate osteoporosis management to improve the assessment, diagnosis, and treatment of osteoporosis in postmenopausal women. Staff training was provided before project implementation.
耗时 0.18096 秒，为您在
48229835
条记录里面共找到 498 篇文章 [XML]